Superorganism is a US-based venture capital firm launched in 2023 to back biodiversity-first startups. Positioned as the conservationist on the cap table, the firm is the first of its kind with a dedicated thesis around preserving nature through scalable technology.
In January 2026, Superorganism closed its debut fund with $25.9 million in commitments. LPs include the Cisco Foundation, AMB Holdings, Builders Vision, and individuals like Jeff Jordan of a16z. The fund plans to invest in approximately 35 companies, with check sizes ranging from $250K to $500K.
Superorganism targets three key categories: technologies that prevent extinction, climate-linked solutions that protect ecosystems, and infrastructure tools that enable conservation at scale. The fund also donates 10% of its profits to conservation efforts.
With 20 companies already backed, the fund is off to a fast start, with portfolio companies like Spoor—an AI platform using computer vision to track bird migration for wind turbine developers—demonstrating the real-world impact of their model. The team emphasizes portfolio diversity across industries and technologies, aiming for long-term ecological and financial sustainability.
Leadership
Superorganism is led by co-founders Kevin Webb and Tom Quigley. Webb came from a background in angel investing with a focus on biodiversity, while Quigley brought operational and sector experience. Together, they’ve positioned the firm as a first-mover in biodiversity venture.
Investment Strategy
Superorganism backs early teams building scalable solutions that preserve nature and ecosystems. The firm’s approach combines impact-driven investing with strong tech fundamentals. It seeks mission-aligned founders who can balance innovation with ecological responsibility. Portfolio construction is designed to weather market cycles by spreading across sectors and use cases.
Notable Investments
The firm has invested in 20 startups so far, including Spoor, which helps wind developers mitigate harm to bird populations using AI. Another portfolio company, Inversa, turns invasive species into leather goods. Their deal flow spans from nature monitoring tools to materials innovation.
Notable Exits
As a new fund, no exits have been disclosed yet, but several companies have secured regulatory and commercial traction early in their lifecycle.
Other
Superorganism gives founders a competitive edge in working with regulators, NGOs, and sustainability-minded corporate partners. Founders benefit from the firm’s credibility in conservation circles, paired with startup fluency and early-stage capital.
United States
